SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Uni-Pixel, Inc. of Class Action Lawsuit and Upcoming Deadline -- UNXL

NEW YORK, Aug. 2, 2013 (GLOBE NEWSWIRE) -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP has filed a class action lawsuit against Uni-Pixel, Inc. ("Uni-Pixel" or the "Company") (Nasdaq: UNXL ) and certain of its officers. The class action, filed in United States District Court, Southern District of Texas, and docketed under 13-cv-01649, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired securities of Uni-Pixel between December 7, 2012 and May 31, 2013 both dates inclusive (the "Class Period"). This class action seeks to recover damages against the Company and certain of its officers and directors as a result of alleged violations of the federal securities laws pursuant to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.

If you are a shareholder who purchased Uni-Pixel securities during the Class Period, you have until August 5, 2013 to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com . To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, x237. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, number of shares purchased, and losses.

Uni-Pixel manufactures fingerprint-resistant and hard coat protective cover films for touch screen-enabled devices. The Company's key product is UniBoss, a copper-mesh film that sits under the glass in touch-sensitive devices, which the  Company claims is cheaper to manufacture and more responsive than other competing technologies.

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose material adverse facts concerning: (1) the nature and commercial potential of the agreements recently entered into by Uni-Pixel with other companies to develop, manufacture and distribute UniBoss; and (2) Uni-Pixel's ability to successfully produce UniBoss in commercially meaningful volumes without serious mechanical failures, and at the price points and margins, projected by management.

On May 20, 2013, after the market closed, the Company disclosed that a PC manufacturer with whom it is collaborating recently reported delays with associated operating system software that would delay the appearance of products utilizing UniBoss technology from the third quarter into the fourth quarter of 2013. On this news, Uni-Pixel securities declined $2.48 per share over 9.5%, to close at $23.47 per share on May 21, 2013.

On May 31, 2013, Seeking Alpha published an article in which the author stated, among other things, that he had spoken with two former Uni-Pixel sales employees who told him that Uni-Pixel had yet to prove the viability of UniBoss by the time they had left the company, and expressed significant skepticism about Uni-Pixel's ability to successfully produce UniBoss. One of these employees predicted that "Uni-Pixel would ultimately fail when it came time to produce UniBoss in material volumes and in a real-life setting outside of the lab." On this news, Uni-Pixel securities declined $4.57 per share over 23%, to close at $15.21 per share on May 31, 2013.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and San Diego, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com .

Robert S. Willoughby Pomerantz Grossman Hufford Dahlstrom & Gross LLP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 2

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 4

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 8

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading

Top 5 Most Recently Viewed Articles

Nuvini Group Limited Achieves Remarkable Growth in 2024

Updated Category News Views 242

Outstanding Financial Performance Delivered by Nuvini Group NEW YORK — Nuvini Group Limited (Nasdaq: NVNI) has released its financial results for the first half of 2024, demonstrating impressive growth across various metrics. The company continues to set the bar high in the realm of private SaaS B2B acquisitions in Latin America. Growth Metrics Highlight Success The...

Continue Reading
MarketFully Expands Reach with Social Element Acquisition

Updated Category News Views 168

MarketFully Enhances Capabilities with New Acquisition Markfully, the leader in InContent Marketing, has broadened its horizons through the acquisition of a prominent global social media agency, Social Element. This strategic move is set to amplify MarketFully's capacity for delivering multilingual content marketing solutions, particularly across social media platforms....

Continue Reading
Lone Star Family Health Center Partners with athenahealth to Enhance Patient Care

Updated Category News Views 717

Lone Star Family Health Center Partners with athenahealth for Enhanced Care Lone Star Family Health Center (LSFHC), a notable health service provider, has made a major decision to transition to athenaOne, a cutting-edge suite of medical software. This strategic move aims to elevate patient care experiences and health outcomes substantially. athenahealth, well-known for...

Continue Reading
Promising Long-Term Results for Zeposia in Multiple Sclerosis

Updated Category News Views 123

Zeposia (ozanimod): A Breakthrough in Multiple Sclerosis Treatment Bristol Myers Squibb has recently shared compelling long-term findings from the Phase 3 DAYBREAK trial on Zeposia (ozanimod). This promising oral treatment has proven effective in managing relapsing forms of multiple sclerosis (MS). The results underscore Zeposia's sustained effectiveness and safety, which...

Continue Reading
Encompass Health Expands Its Rehabilitation Services in Florida

Updated Category News Views 268

Encompass Health Opens New Rehabilitation Hospital Encompass Health has recently made a significant impact in the healthcare landscape by launching a new facility. The Encompass Health Rehabilitation Hospital of St. Petersburg is now officially open to patients, marking the company's 25th location in Florida. Quality Care for Patients This facility is aimed at improving...

Continue Reading